Robin Kramer

Robin C.
Kramer currently works at Armata Pharmaceuticals, Inc., as Chairman from 2023, Biogen, Inc., as Chief Financial Officer & Executive Vice President from 2025, The American Institute of Certified Public Accountants, as Member, Massachusetts Society of Certified Public Accountants, Inc., as Member, and AICPA Foundation, Inc., as Member.
Ms. Kramer also formerly worked at Gillette Co., as Director-External Reporting & Accounting from 2004 to 2005, Probus Insurance Company Europe DAC, as Director from 2016 to 2018, Board of Public Accountancyg, as Director from 2011 to 2015, Samsung Bioepis Co., Ltd., as Director from 2020 to 2022, Center for Women & Enterprise, as Director from 2020 to 2024, The Hertz Corp., as Chief Accounting Officer & Senior Vice President from 2014 to 2018, Fisher Scientific International, Inc., as Chief Accounting Officer from 2005 to 2007, Ernst & Young LLP, as Partner from 2002 to 2004, Deloitte & Touche LLP, as Audit Partner from 2007 to 2014, Arthur Andersen LLP, as Partner from 1987 to 2002, and Hertz Global Holdings, Inc., as Chief Accounting Officer & Senior Vice President in 2018.
Ms. Kramer received her undergraduate degree from Salem State University.